Company Says Oral COVID-19 Treatment Not Effective In Patients With Mild, Moderate Illness In Small Study

Reuters (10/19, Roy, Leo, Banerjee) reports “Atea Pharmaceuticals Inc’s experimental COVID-19 antiviral pill [AT-527], being developed with Roche, failed to help patients with mild and moderate COVID-19 in a small study of mostly low-risk patients.” The c...